Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice

Recent work has suggested that fibroblast growth factor-21 (FGF-21) is a useful biomarker of mitochondrial disease (MD). We routinely measured FGF-21 levels on patients who were investigated at our centre for MD and evaluated its diagnostic performance based on detailed genetic and other laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Morovat, Alireza, Weerasinghe, Gayani, Nesbitt, Victoria, Hofer, Monika, Agnew, Thomas, Quaghebeur, Geralrine, Sergeant, Kate, Fratter, Carl, Guha, Nishan, Mirzazadeh, Mehdi, Poulton, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575582/
https://www.ncbi.nlm.nih.gov/pubmed/28825656
http://dx.doi.org/10.3390/jcm6080080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575582/
https://www.ncbi.nlm.nih.gov/pubmed/28825656
http://dx.doi.org/10.3390/jcm6080080

Ejemplares similares